Recombinant Rat Serum Albumin Protein (HEK293)，His

Serum albumin, a vital blood protein synthesized primarily in the liver, plays a crucial role in maintaining oncotic pressure, transporting various substances, and regulating blood volume. Due to its significant physiological functions and abundance in plasma, recombinant human serum albumin (rHSA) has garnered significant attention in biomedical research and clinical applications. The development of rHSA has emerged as a promising alternative to human serum albumin sourced from blood donors, mitigating risks of transmission of infectious agents and providing a sustainable supply for therapeutic uses. Moreover, rHSA can be engineered for enhanced properties, such as increased stability and improved binding affinity for drugs and other molecules, thereby expanding its application in drug delivery, as a stabilizing agent in biopharmaceutical formulations, and in various clinical settings requiring volume expansion or protein supplementation. Recent advances in recombinant DNA technology facilitate the production of rHSA with high purity and yield, rendering it increasingly viable for widespread therapeutic use. Furthermore, ongoing research aims to better understand its interactions within the body and its potential modifications to optimize its efficacy and safety profiles in diverse medical applications. This background underscores the significance of rHSA research in addressing both clinical needs and improving patient outcomes, making it a focal point of contemporary biomedical studies.